You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microglial Activation

Showing 1 - 25 of 4,868
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)

Not yet recruiting
  • Alzheimer Disease
  • [11C]-UCB-J
  • +3 more
  • Lille, France
  • +2 more
Jun 12, 2023

Does Microglial Activation Promote Lesion Growth and Progression

Enrolling by invitation
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Nov 1, 2022

    ALS Trial ([11C]CPPC PET ligand)

    Not yet recruiting
    • ALS
    • [11C]CPPC PET ligand
    • (no location specified)
    Jan 9, 2023

    Microglial Activation in the CNS

    Active, not recruiting
    • Multiple Sclerosis
    • Imaging
    • Turku, Finland Proper, Finland
      Turku PET Centre
    May 31, 2022

    Microglial Activation inMS Patient Cohort at Risk of Progression

    Active, not recruiting
    • Multiple Sclerosis
      • Turku, Finland Proper, Finland
        Turku PET Centre
      May 31, 2022

      Multiple System Atrophy, Multiple System Atrophy, Cerebellar Variant, Multiple System Atrophy, Parkinson Variant (Disorder)

      Completed
      • Multiple System Atrophy
      • +3 more
      • Boston, Massachusetts
        Movement Disorders Clinic, 60 Fenwood Road
      Aug 18, 2022

      Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Irving Medical Center
      Jan 10, 2022

      Neuropsychiatric Syndromes Trial in Houston (PET with radiotracer [11C]PBR-28 ( or [11C]ER176), Affective challenge)

      Recruiting
      • Neuropsychiatric Syndromes
      • PET with radiotracer [11C]PBR-28 ( or [11C]ER176)
      • Affective challenge
      • Houston, Texas
        BBSB at UTHealth
      Sep 27, 2021

      Multiple Sclerosis Trial in Boston ([F-18]PBR06, [C-11]Methylreboxetine)

      Recruiting
      • Multiple Sclerosis
      • Boston, Massachusetts
        Partners MS Center, 60 Fenwood Road
      Jul 26, 2021

      Alzheimer Trial in New York (11C-ER176, 18F-MK6240, 18F-Florbetaben)

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Irving Medical Center
      Jul 28, 2021

      CBD, Healthy Trial in New Haven ([11C]PBR28, Low-dose lipopolysaccharide, Intradermal Capsaicin)

      Recruiting
      • CBD
      • Healthy
      • [11C]PBR28
      • +2 more
      • New Haven, Connecticut
        Connecticut Mental Health Center
      Sep 3, 2021

      Microglial Cells Activation Imaging Using PET-CT With 18F-DPA714

      Recruiting
      • Microglial Cells Activation Imaging
        • Fuzhou, China
        • +1 more
        Nov 21, 2021

        Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate

        Recruiting
        • Fibromyalgia
        • +2 more
        • Low dose naltrexone
        • +3 more
        • Zürich, Switzerland
          Balgrist Campus
        Feb 20, 2022

        Parkinson Disease Trial in Nantes, Rennes, Tours ([18F]DPA-714 PET scan)

        Recruiting
        • Parkinson Disease
        • [18F]DPA-714 PET scan
        • Nantes, France
        • +3 more
        Sep 17, 2021

        Multiple Sclerosis, Alzheimer's Disease Trial in Boston ([F-18]PBR06, [C-11]PBR28)

        Recruiting
        • Multiple Sclerosis
        • Alzheimer's Disease
        • Boston, Massachusetts
          Partners MS Center, 60 Fenwood Road
        Dec 9, 2020

        Neurotropism and Neuroinflammation in COVID-19 Delirium.

        Recruiting
        • Covid19
        • +2 more
        • serology testing profiles description
        • +4 more
        • Toulouse, France
        • +1 more
        Sep 3, 2021

        Autism Spectrum Disorder Trial in Los Angeles (Minocycline)

        Suspended
        • Autism Spectrum Disorder
        • Los Angeles, California
          UCLA
        Aug 6, 2020

        Microglia Activation in Asthma

        Recruiting
        • Asthma
        • Whole lung antigen challenge (WLAC)
        • [18F]FEPPA
        • Madison, Wisconsin
          University of Wisconsin Madison
        Jul 14, 2022

        Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)

        Recruiting
        • Multiple Sclerosis
        • +2 more
        • Paris, France
          Hôpital Saint-Antoine - Service de Neurologie
        Jan 27, 2020

        Multiple Sclerosis Trial in Boston ([F-18]PBR06)

        Not yet recruiting
        • Multiple Sclerosis
        • Boston, Massachusetts
          Partners MS Center, 60 Fenwood Road
        Jun 10, 2019

        Ischemic Stroke Trial in Munich ([18F]-GE-180 PET, 3T MRI, immune cell profiling in blood)

        Recruiting
        • Ischemic Stroke
        • [18F]-GE-180 PET
        • +2 more
        • Munich, Germany
        • +1 more
        Oct 5, 2021

        REM Sleep Behavior Disorder Trial in Camperdown, Oxford (PXS-4728 (A), Matching Placebo (B))

        Not yet recruiting
        • REM Sleep Behavior Disorder
        • PXS-4728 (A)
        • Matching Placebo (B)
        • Camperdown, Sydney, Australia
        • +1 more
        Jun 6, 2023

        Obesity Trial in New Haven (Intralipid Infusion)

        Not yet recruiting
        • Obesity
        • Intralipid Infusion
        • New Haven, Connecticut
          Yale University
        Oct 5, 2022

        Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

        Recruiting
        • Relapsing Multiple Sclerosis
        • Boston, Massachusetts
          Partners MS Center, 60 Fenwood Road
        Jul 20, 2021

        Healthy Volunteers, Amyotrophic Lateral Sclerosis Trial in New Haven ([18F]PBR06)

        Completed
        • Healthy Volunteers
        • Amyotrophic Lateral Sclerosis
        • New Haven, Connecticut
          Molecular NeuroImaging, LLC
        Mar 22, 2019